The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium’s position statement
Open Access
- 14 December 2018
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 19 (3) , 625-632
Abstract
No abstract availableKeywords
Funding Information
- U.S. Food and Drug Administration (5U18FD005320‐05)
- American Society of Transplantation
- Astellas Pharma US
- Bristol-Myers Squibb
- Novartis
- CSL Behring
- Sanofi
- Shire
- American Society of Transplant Surgeons
This publication has 31 references indexed in Scilit:
- Frailty and Early Hospital Readmission After Kidney TransplantationAmerican Journal of Transplantation, 2013
- Analysis, evaluation and adaptation of the ReTransQoL: a specific quality of life questionnaire for renal transplant recipientsHealth and Quality of Life Outcomes, 2013
- Is Kidney Transplantation for Everyone? The Example of the Older Dialysis PatientClinical Journal of the American Society of Nephrology, 2009
- Measuring symptom experience of side-effects of immunosuppressive drugs: the Modified Transplant Symptom Occurrence and Distress ScaleTransplant International, 2008
- Development and validation of a French patient-based health-related quality of life instrument in kidney transplant: the ReTransQoLHealth and Quality of Life Outcomes, 2008
- Quality of life in adult survivors beyond 10 years after liver, kidney, and heart transplantationTransplantation, 2003
- The Transplant Effects Questionnaire (TxEQ): The development of a questionnaire for assessing the multidimensional outcome of organ transplantation — example of end stage renal disease (ESRD)British Journal of Health Psychology, 2002
- Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric TransplantNew England Journal of Medicine, 1999
- INCIDENCE, DETERMINANTS, AND CONSEQUENCES OF SUBCLINICAL NONCOMPLIANCE WITH IMMUNOSUPPRESSIVE THERAPY IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1995
- Disease-Specific Questionnaire for Patients with a Renal TransplantNephron, 1993